5 reductase (GR, an important antioxidant enzyme), and lactate dehydrogenase (LDH) [23] . These aldehydes have also been demonstrated to inhibit cysteine proteases (cathepsins B, L and S) of the lysosomal cathepsin family in macrophage cell lysates in a concentration-dependent manner [7] . Under the same concentrations glucose or proteins pre-glycated with glucose had no effect [7, 23] . This inhibition has been suggested to arise from aldehyde-induced modification of the thiol groups of these enzymes [7, 23] . It has also been suggested that elevated levels of free low molecular mass aldehydes (GA, GO and MGO) play an essential role in diabetes-associated atherosclerosis via the formation of glycated low-density lipoprotein particles which may contribute to lipid-loading of macrophage cells in the artery wall [24] . The aim of the current study was therefore to test the hypothesis that elevated levels of glucose and reactive aldehydes, and pre-glycated proteins (generated by glucose and reactive aldehydes) may modulate the activity of the proteasome system, as this system appears to play an essential role in degradation of these modified proteins [1] .
Materials and methods

Materials
Proteasomal enzyme activity was quantified using the pro-fluorescent peptides N-SucLeu-Leu-Val-Tyr-AMC (chymotrypsin-like activity), and Boc-Leu-Ser-Thr-Arg-AMC (trypsinlike activity) purchased from Sigma-Aldrich (Castle Hill, NSW, Australia). Caspase-like activity was examined using Ac-Nle-Pro-Nle-Asp-AMC (Auspep, Parkville, VIC, Australia). All substrates were prepared as 100 x stocks in DMSO (10 mM for chymotrypsin and caspase substrates, 60 mM for trypsin) [21] and stored at -20 ºC. Glucose and sodium dihydrogen orthophosphate monohydrate (Na 2 HPO 4 .H 2 O) were obtained from Merck (Kilsyth, VIC, 6 Australia), digitonin from Calbiochem (La Jolla, CA, USA), disodium hydrogen orthophosphate dodecahydrate (Na 2 HPO 4. 12 H 2 O) from Univar (Seven Hills, NSW, Australia), dithiothreitol was from Astral Scientific (Gymea, NSW, Australia), and Tris hydrochloride from Amresco (Solon, OH, USA). All other chemicals were obtained from Sigma-Aldrich (Castle Hill, NSW, Australia) unless otherwise noted. All solutions were prepared using nanopure water (Milli Q system, Millipore-Waters, Lane Cove, NSW, Australia) and treated with washed Chelex-100 resin (Bio-Rad, Regents Park, NSW, Australia) to remove trace metal ions.
Preparation of glycated BSA
Extensively glycated BSA was prepared by incubation of BSA (50 mg mL conditions and an atmosphere of humidified 5% CO 2 . Control BSA samples were incubated in a similar manner in the absence of glucose [7] . BSA modified by methylglyoxal (MGO), glycolaldehyde (GA) or glucose was generated by incubating BSA (80 mg mL -1 ) with MGO or glucose at 10 and 200 mM, or GA at 10 mM, for 17 h at 37 ºC in 50 mM phosphate buffer (pH 7.4). Control BSA was incubated in a similar manner in the absence of MGO, GA or glucose.
Immediately after incubation, protein samples were passed through 2 successive PD10 columns (Amersham Bioscience, Castle Hill, NSW, Australia) using chelexed-treated 50 mM phosphate buffer, pH 7.4, as the eluting buffer to remove unbound MGO, GA or glucose. With the exception of BSA incubated with glucose for 17 h where little adduction occurs, these incubations result in the formation of BSA with multiple covalently-bound sugar molecules or aldehyde groups [25] [26] [27] (see also below). Protein concentrations were determined using the Pierce (Rockford, IL, USA) bicinchoninic acid (BCA) assay with commercial BSA used as a standard [28] .
Characterization of glycated BSA
The nature and extent of BSA glycation was assessed for each condition by HCl hydrolysis of triplicate samples as described previously [29] , with modifications according to Zeng and Davies [30] . Briefly, vials containing 0. 
Preparation of cell extracts for proteasome activity measurement
Cell extracts containing proteasomes were prepared as described previously [21] . Briefly, cell pellets were resuspended in 500 µL of homogenisation buffer (50 mM Tris-HCl, pH 7.5, 250 mM sucrose, 5 mM MgCl 2 , 2 mM ATP, 1 mM DTT and 0.5 mM EDTA) containing 0.025% (w/v) digitonin. ATP was employed to prevent dissociation of the 26S proteasome into its components and to ensure that 26S, and not 20S activity, was measured [21] . Resuspended cells were incubated on ice for 5 min to allow permeabilisation by digitonin, and were then transferred to glass tubes (8 x 34 mm; Beckman, Palo Alto, CA, USA). The cytosol was forced out by centrifugation at 20,000 g for 15 min at 4 ºC using a Beckman centrifuge (120/1, Palo Alto, CA, USA). The optimal protein concentration for the proteasome activity assay was determined to be 11-12 µg protein/reaction, with dilutions made using homogenisation buffer.
Treatment of cell extracts with free aldehydes, glucose and glycated BSA
The effect of aldehydes and glucose on proteasome activity, was examined using cell 
Proteolytic activity measurement and analysis
Immediately after completion of the incubations with the required materials (free aldehyde, glycated BSA, epoxomicin, or no additives), proteolysis was measured by a continuous assay of peptidase activity using fluorescence detection [21] . Samples were prepared in reaction buffer (50 mM Tris-HCl, pH 7.5, 40 mM KCl, 5 mM MgCl 2 , 0.5 mM ATP, 1 mM DTT, 0.5 mg/ml BSA) with 100 µM for the chymotryptic and caspase substrates, or 600 µM tryptic substrate. Fluorescence (λ ex 360 nm, λ em 460 nm) was measured using a Cytofluor II plate reader every minute for 30 min. Potential contributions from non-proteasomal enzyme activity were examined using the proteasome-specific inhibitor epoxomicin with proteosome activity considered to be the fraction of fluorescence increase that was sensitive to this agent; fluorescent change due to proteasomal activity were therefore calculated as the difference in the rate of fluorescence change over time (ΔFU/min) between determinations made in the presence (preincubation with 20 µM reagent at 21 ºC for 30 min) and absence of this agent [21] .
Statistical analyses
Data from all enzymatic activity measurements are expressed as mean ± SEM from 3 or more separate experiments, each assayed in triplicate. HPLC samples were analysed from triplicate experiments. Statistics analysis was performed using Prism 4.03 (GraphPad software, San Diego, CA, USA). For pair comparisons, paired t tests were employed. For multiple comparisons, oneway analysis of variance (ANOVA) with Newman-Keuls Multiple Comparison test was employed. For the AGE and amino acid analyses one-tailed unpaired t-tests were employed with the glycated BSA samples to the corresponding control. Results were considered statistically significant at the P < 0.05 level.
Results
Effect of glucose on proteasomal enzyme activities in J774A.1 cell extracts
Incubation of cell extracts with 5 or 20 mM glucose at 21 ºC for 5 min had no effect on chymotrypsin-and trypsin-like activities as compared with glucose-free controls, although a dose-dependent trend towards an enhancement in activity was observed ( Fig. 1 ). With 20 mM glucose a significant increase (ca. 1.5-fold) in caspase-like activity was observed compared to the no glucose condition, but this was not significant when compared to the 5 mM glucose system.
Effect of reactive aldehydes on proteasomal enzyme activities in J774A.1 cell extracts
The effect of reactive aldehydes on the proteasomal enzyme activities were investigated by incubation of cell extracts of J774A.1 cells with GA, GO or MGO over the concentration range 0.25 -20 mM, at 21 ºC for 5 min. Proteasomal activities were then quantified as described above. Treatment of the proteasomal preparations with all three reactive aldehydes resulted in a dose-dependent increase in chymotrypsin-like activity ( Fig. 2A ). This increase was statisticallysignificant at 10 mM for each aldehyde. However, at the highest concentration examined there was attenuation in activity found with GA treatment, whereas no further increase was observed with GO, and the activity was further enhanced with MGO. Thus the chymotrypsin-like activity of the cell extracts of J744A.1 cells differentially responsive to MGO, GO and GA.
Differences in the response to aldehyde treatment were also observed with the caspaselike activity (Fig. 2B ). This activity was relatively insensitive to MGO treatment with the exception of the highest concentration examined. In the cases of GA-and GO treatment, a dosedependent enhancement in caspase-like activity was apparent with a significant increase detected at 10 mM. Interestingly, a trend towards a suppression of caspase-like activity was observed at very high aldehyde levels (20 mM GO, 10 mM MGO) when compared to control, but this did not reach statistical-significance.
Trypsin-like activity was significantly modulated by MGO at 0.5 mM and above, resulting in a significant enhancement of activity, with this stimulation being concentration 13 dependent (Fig. 2C) . In contrast, GO and GA only increased trypsin-like activity at high concentrations (10 and 20 mM for GA and GO, respectively).
Characterization of BSA modification by glucose and reactive aldehydes
Modification of the glycated and control BSA was characterized by HPLC analysis.
Incubation of BSA with 200 mM MGX resulted in the detection of significant levels of the AGEs CML, CEL, MG-H1, MGH-2a and MG-H2b (Fig. 3 ) and 58% loss of parent Arg (Fig. 3) . Lys residues were also depleted but this was not quantified (see below). Significant Arg modification was also evident upon incubation with 10 mM MGX, as evidenced by elevated levels of CML, MG-H1, MG-H2a and MG-H2b, and loss of 23% of the parent Arg (Fig. 3 ). Reaction at Lys residues was less marked in this case as judged by the extent of CEL formation (Fig. 3) . With GA as the modifying agents, elevated levels of CML were detected together with a small, but significant, loss of Arg (Fig. 3) .
Incubation of BSA with glucose for 8 weeks resulted in the formation of very high levels of CML (over 30-fold greater than 10 mM GA, and over 300-fold greater than MGX), as well as significant amounts of CEL. A significant (22%) loss of Arg was also detected, which is not accounted for by the concentration of AGEs detected by HPLC, consistent with the formation of additional products such as N ω -carboxymethylarginine (CMA), which is known to be formed upon incubation of protein with glucose for prolonged periods, but which is susceptible to acid hydrolysis [31] . Parent Lys was also depleted in these samples consistent with the formation of Lys-derived AGEs (CML, CEL), but this was not quantified absolutely, due to variability in Lys derivatization by OPA. No significant AGE formation, or parent Arg, was observed upon incubation of BSA with 10 mM or 200 mM glucose for 17 h (Fig. 3) .
Effects of native and glycated proteins on proteasomal enzyme activity
The effects of the glycated and control BSA on proteasome activity were examined by incubating J774A.1 cell extracts with three different concentrations of native or modified protein (0.4, 1 and 4 mg protein mL -1 ) for 5 min at 21 ºC. Initial studies examined control (native) incubated BSA (Fig. 4) . Chymotrypsin activity was sensitive to inhibition by the highest concentration of BSA incubated overnight, or for up to 8 weeks at 37 o C (Fig. 4A ). Caspase-like activity was decreased significantly on incubation with the highest concentration of native BSA incubated for 8 weeks, but not at shorter times or with lower concentrations (Fig. 4B ). Trypsinlike activity was unaffected (Fig. 4C ). In the light of this data, subsequent comparisons were made versus the corresponding samples incubated with native BSA for the same period.
BSA pre-glycated with glucose for 17 hr had no significant effects on proteasomal activity compared to the incubated protein control (data not shown). In contrast, BSA glycated by incubation with 1 M glucose for 8 weeks, gave rise to a significant inhibition of both the chymotrypsin-and caspase-like activities at the highest concentration of BSA used compared to the incubated protein control. The trypsin-like activity was not affected (Fig. 5) . With the highest protein concentration (4 mg/ml) an apparent negative gradient was observed; this arises from the subtraction of the fluorescence changes observed with the epoxomicin controls from the glycated protein data, and is believed to reflect inhibitory effects of the native or glycated BSA on other proteolytic systems present in the cell extracts (e.g. calpains and lysosomal cathepsins) [21] .
No significant inhibitory effects on the trypsin-like activity of the proteasomal extracts was observed with BSA pre-glycated with glucose over the range of BSA and glucose concentrations, and glycation conditions, examined (Fig. 5) . In contrast to the other activities (see above) a significant increase in trypsin-like activity was observed with the highest concentration of BSA modified with either 10 mM or 200 mM glucose for 17 h (Fig. 5F ).
The effects of BSA glycated by reactive aldehydes on proteasomal enzyme activities were examined in a similar manner to that outlined above, with the BSA (0.4, 1 or 4 mg protein mL -1 )
pre-incubated 10 mM GA (GA (10 significantly inhibited both the chymotrypsin-and caspase-like activities ( Fig. 6A-D) . In contrast, this material stimulated trypsin-like activity (Fig. 6E) . BSA-modified with10 mM MGO had no effect upon any of the measured proteasomal activities at any of the protein levels examined. With BSA modified with 200 mM MGO, an inhibition of caspase-like activity was observed at all the protein concentrations examined (Fig. 6C-D) . In addition, inhibition of both the chymotrypsin and trypsin activities was detected with the highest concentrations (4 mg protein mL -1 ) of this modified protein ( Fig. 6B and F) .
Discussion
This study has examined the effects of short-term exposure to glucose, reactive aldehydes and pre-glycated proteins on the activities of one of the major components of the intracellular protein removal systems, the proteasome. One of the defining features of diabetes is hyperglycaemia, with elevation of blood glucose levels from 5 mM to up to ca. 30 mM in extreme cases [32] . This elevation is glucose is associated with elevations in the levels of reactive aldehydes derived from glucose and other metabolic processes, and the generation of glycated / glycoxidised proteins [32] . Elevated levels of these materials have been detected in people with diabetes and correlate with the extent and duration of disease [33] [34] [35] [36] [37] . Thus increases in the level of glycated haemoglobin, a commonly used marker of hyperglycaemia, have been shown to both correlate with, and predict future cardiovascular disease [35] [36] [37] . The effects of these materials on proteasome function have been studied here in cell extracts from a macrophage-like cell line, as such cells play a key role in the development of atherosclerosis -the major macrovascular complication of diabetes, and the most important contributing factor to mortality and morbidity in people with diabetes [38] . Partially-purified cell extracts were used in these studies as modulation of the proteasomal system in intact cells by these agents is difficult to assess without accompanying perturbation of other aspects of cell metabolism. In their role as scavenging cells of the immune system, macrophages are likely to be exposed to glycated proteins as well as elevated glucose and reactive aldehydes [6, 39] . However the effects of glucose, reactive aldehydes and glycated proteins upon cellular metabolism and proteasomal function are not yet fully understood, though there is considerable current interest in this area, with previous studies having examined, for example, the rates of degradation of glycated / glycoxidized proteins in other cell types and tissues [3, 22, [40] [41] [42] , and the effect of reactive aldehydes and glycated proteins on the other major proteolytic system of cells, the endolysosomal system (e.g. [3, 7, 43] ).
The data reported here demonstrate that the effects of glucose, reactive aldehydes and glycated proteins on the three major activities of the proteasome are diverse and complex, with both stimulation and inhibition detected under different conditions. The data obtained indicate that free reactive aldehydes induce more pronounced effects on proteasomal enzyme activities than glucose itself under the same conditions. This is consistent with previous data that have indicated that reactive aldehydes are considerably more reactive (up to 20,000-fold) than glucose itself [15, 25] , though these aldehydes are present at much lower levels (see below). Glucose is the most abundant, but is also considered to be the least deleterious of the common sugars present in human [3] . In vivo studies have suggested that elevated levels of glucose alone are insufficient to accelerate diabetes-associated atherosclerosis [44] . The results of the current study are also consistent with previous studies that have reported that elevated levels of glucose did not inhibit some cytosolic (e.g. glyceraldehyde-3-phosphate dehydrogenase, GAPDH, and glutathione reductase) and lysosomal enzymes (e.g. the cysteine-dependent cathepsins, B and L), in vitro, whereas reactive aldehydes showed marked inhibitory effects [7, 23] .
In contrast to these previous reports of enzyme inhibition induced by reactive aldehydes (see above), the major effect observed in the current study was a stimulation of proteasomal enzymatic activity. A similar enhancement of nuclear proteasomal activity has been detected in intact cells treated with GO [45] , though the exact mechanism by which this occurs has not been identified. A number of treatments, such as incubation with basic polypeptides, SDS and fatty acids have previously been shown to activate the 20S proteasome by a mechanism that involves changes in protein conformation [20] . Thus alterations in the conformation of the β subunits have been proposed to enhance catalytic activity, and changes in the α ring may facilitate substrate entry to the catalytic core [20] . In the case of the 26S proteasome examined here, reactive aldehyde-induced alteration to either the lid or base of the 19S proteasome that delivers substrates to the proteolytic core may also play a role. As the species used to assess enzymatic activity in the current study were small peptides, rather than large proteins, changes in the conformation of the β subunits may be the most likely cause of the observed stimulation of activity, as the entry of these (unstructured / unfolded) peptides in to the protein core are less likely to be affected by steric factors, though this obviously requires further study. It has also been reported that post-translational modifications of the proteasome complex (or its subunits) including phosphorylation and acetylation, can modulate proteasomal activities [19, 46, 47] . Thus phosphorylation of the α subunits appears to enhance activity of the proteasome in mammalian cells, possibly by inducing conformational changes that modulate substrate accessibility [46] .
Modification of specific Arg or Lys residues on proteasomal subunits by the reactive aldehydes under study (cf. data in Fig. 3 ) may induce similar conformation changes, and it is therefore of interest to note that enhanced levels of glycated (N ε -carboxymethyllysine containing) proteasome protein have been detected in aging cells [48] . In contrast, acetylation of the N-terminal Thr residue of the active β subunits and the α subunits results in inactivation of 20S proteasome [19, 47] . A number of oxidants have also been shown to alter proteasome activity, with both inhibition [49, 50] and activation reported [51] . Up-regulation of proteasome activity may be of considerable biological relevance in light of the key role that this complex plays in the degradation of inhibitory proteins, such as IκB, which prevents NF-κB activation and signalling [52] , as has been reported in atherosclerotic plaques from people with diabetes [53] .
The data reported here are in contrast to a previous study that reported an inhibitory effect of GO on proteasomal enzyme activities in vitro [22] . There are however, a number of significant differences between these two studies, with this previous investigation showing that GO inhibited the 20S proteasome purified from human placenta after a 30 min incubation period [22] ; this preparation lacks the regulatory subunits present on the 26S form, and hence effects of the reactive aldehydes on substrate accessibility and the control of this process, would not have been detectable in this earlier study. The 20S form of the proteasome was not examined in the current study, as the majority of protein turnover in eukaryotic cells appears to occur via the 26S complex [21, 54] . Furthermore, whilst the short incubation times employed in the current study may be sufficient to alter the conformational structure of the 26S complex in such a way as to allow greater substrate accessibility and thus enhanced activity, the longer incubation times, used by Bulteau and colleagues [22] , may result in the accumulation of more severe damage to the 20S core and a suppression of enzyme activity.
In contrast to the absence of effects induced by free glucose, significant changes in base under physiological conditions [55] . This low level of modification has been confirmed here (Fig. 3) . Subsequent rearrangement of this species to fructosamine or an Amadori product occurs over a much longer time-scale with equilibrium reached by ca. 38 h [55] . Thus it would appear that the formation of low levels of early (reversible) adducts on BSA do not significantly inhibit proteasomal enzymatic activities, whereas the advanced glycation products that are formed in high yield as a consequence of very high glucose concentrations and long term incubation (Fig.   3 ), have marked inhibitory effects. An absence of marked inhibitory effects with the combination 20 of BSA and short-term glucose incubation has also been reported for lysosomal cysteinedependent cathepsins [7] . The inhibition observed with high glucose/long term incubation are consistent with those of Stolzing and colleagues [41] for isolated 20S proteasomes where inhibition of the chymotrypsin-, caspase-and trypsin-like activities was observed on incubation with AGE-BSA (produced by incubation of BSA with 0.25 and 1 M glucose for 6 weeks) for 1 h.
In both the current study and this previous work [41] the caspase-like activity appears to be the most markedly affected, and it is clear from the current data that this inhibition is rapid and can occur in < 5 min.
Reactive aldehydes are known to be generated during glucose degradation (e.g. over a 3 week period at pH 7.4 and 37 °C), and that the presence of proteins, such as HSA, enhances their rate of formation [55] . Elevated levels of these aldehydes have also been detected in human plasma from people with diabetes compared to healthy controls, though there is considerable variation in the reported values [56] [57] [58] . The high reactivity of these aldehydes [55] with nucleophilic sites present on proteins (primarily Arg, Lys, His and Cys side-chains and the Nterminal amino group), limits the concentration of these materials in plasma, and these values represent steady state concentrations at the time of sampling, rather than the overall fluxes of modifying agent to which a protein may be exposed over its lifetime. Whether these plasma levels reflect those present within cells is also unclear, and no specific measurements have been reported for cells. As many of the metabolic processes that generate reactive aldehydes are intracellular (e.g. decomposition of triose phosphates [13] ) it is likely that cellular levels will be higher than those detected in plasma where the levels may reflect primarily glucose autooxidation and efflux of the reactive aldehydes from cells. Higher fluxes might also be expected at sites of inflammation (e.g. within the artery wall during the development of atherosclerosis) as a result of the localisation of enzymes that can generate reactive aldehydes at such sites (e.g. myeloperoxidase which generates GO and MGO from the amino acids serine and threonine [14] ).
It is already established that other products of myeloperoxidase-mediated reactions accumulate on proteins to much higher levels in atherosclerotic lesions than are present in plasma / serum (up to 8-fold greater for apolipoprotein A-I, ca. 100-fold for apolipoprotein B-100 and ca. 115-fold for total protein [59, 60] ). In addition it is well established that there is a marked accumulation of lipid oxidation products, another potential source of reactive aldehydes, in atherosclerotic lesions, with these levels massively exceeding those in plasma [61] . These data suggest that higher levels of reactive aldehydes are likely to be present in atherosclerotic lesion and surrounding tissue, than might be detected in plasma. Thus measurements of steady-state levels of reactive aldehydes in plasma, may provide very limited information on the overall fluxes of reactive aldehydes to which proteins may be exposed within cells and tissues, and particularly at the sites of developing micro-and macrovascular complications in diabetes.
In the light of the above discussion, it is possible that the inhibitory effects observed with highly glycated BSA on the chymotrypsin-and caspase-like activities of the proteasome may arise from reactions of reactive aldehydes formed from glucose over the extended incubation period, rather than from direct glucose reactions (cf. the elevated levels of CML and CEL detected on the BSA incubated with glucose for 8 weeks). This conclusion is consistent with the observed inhibitory effect of BSA pre-glycated with the aldehydes (as opposed to the stimulation detected with the free aldehydes themselves), with this inhibition being most evident with the caspase-and chymotrypsin-like activities. Thus inhibition of both activities was detected with 4 mg mL -1 of BSA pre-glycated with 10 mM GA (in contrast to a stimulation of trypsin-like activity). In contrast, with the same concentrations of MGO, no significant changes in activity were detected, though inhibition was again seen (with all three activities) with higher concentrations of MGO. These data suggest that the species generated by GA, such as CML (cf. Fig. 3 ) have a greater inhibitory effect than those generated by MGO (CEL and MG-H1/2), though whether this is a manifestation of the nature of these products, or their relative yields is unclear. These inhibitory effects of pre-glycated proteins mirror the suppressive effects of similar species on the activity of lysosomal cathepsins [7, 62] .
Previous studies have shown that incubation of MGO with BSA at a molar ratio of 10:1 results in a rapid increase in both irreversible and reversible binding of MGO to BSA and a rapid decrease in free MGO over 24 h [15] . The major sites of irreversible adduction under these conditions are Arg residues with this yielding imidazolones including MG-H1 and MG-H2a/b [15] . Incubation of GA with BSA at a molar ratio of 200:1, results in modification of Lys residues and generates C-2-imine cross-links and CML, with the maximum formation of these products detected after ca. 30 min [63] ; these data are consistent with the results obtained in the current study (cf. Fig. 3 ), where the molar ratios of aldehyde:BSA were 8, 166 and 8 for the 10 and 200 mM MGO, and 10 mM GA conditions respectively. The AGE products formed on the BSA may be responsible for the observed inhibition of enzymatic activity, though it is also possible that this arises from loss of the parent amino acid side chains. Whether, and exactly which, AGE species is / are responsible for inhibition, cannot be discerned from the present data due to the difficulty in generating specific individual modifications, in isolation, on this protein.
However it is clear from the data obtained that the extent of proteasomal enzyme alteration by The mechanism of inhibition may be any of the following: (1) glycation may result in the formation of protein cross links and AGE that stabilize the BSA structure [18, 22, 64] resulting in a slower rate of degradation by 26S proteasome, and hence slower cleavage of the peptide used to assess enzyme activity as a result of competition for active sites [22] ; (2) the glycated BSA may react, of form an adduct, with the nucleophilic oxygen of the Thr-1 residues in the β-type subunits [65] thereby inhibiting activity; (3) the AGE (or oxidation) products may modulate the structure or function of the α ring of catalytic core that facilitates the substrate entry [2, 65] with this resulting in reduced access of the peptide substrate and hence a reduced rate of cleavage; or (4) the glycated protein may modulate (or block) the activity of 19S regulatory subunits, that control the access of substrates to the core [65] . Which of these mechanisms are operative in the current study cannot be determined from the current data, and further studies are required to elucidate this point.
One imitation of the current investigation is the use of cell extracts that contain the proteasome, rather than highly purified preparations. The former were employed due to difficulties in isolating sufficient active 26S complex from cells, without significant inactivation and / or loss of the 19S subunits that would compromise data analysis. However the cruder cell extracts are likely to contain other non-proteasomal proteases, such as calpains and possibly lysosomal cathepsins [21] . Possible contributions of these non-proteasomal enzymes to the observed proteolytic activity was minimised by quantifying activity at pH 7.4, where most lysosomal enzymes show little activity [21] , and by including parallel epoxomicin-treated samples. Subtraction of residual activity obtained in the presence of this specific proteasomal 24 inhibitor [66] , from the total activity, provided data that has been ascribed to the proteasome [21] .
However, in some experiments this resulted in an apparent "negative" activity which is consistent with the glucose / free aldehyde or glycated proteins also inhibiting non-proteasomal activity in the samples, resulting in activities lower than those of the epoxomicin controls. Potential circumvention of this effect by either pre-or post-treating the incubations with epoxomicin was considered but not attempted as this would result in different overall incubation periods and potentially misleading data. Blockade of other contributing proteolytic activities by use of inhibitors was not attempted due to the diverse and unknown nature of all of these activities and the non-availability of specific inhibitors.
In conclusion, glycated proteins generated by either reactive aldehydes or long-term exposure to high glucose concentrations has been shown to inhibit the chymotrypsin-, caspaseand to a lesser extent the trypsin-like activities of proteasomal fractions from J774A.1 cells. This Values for control BSA samples taken through identical protocols have been subtracted from the treatment data; in all cases these control data were typically < 0.2 mmol AGE/mole Gly. Data for parent amino acid are expressed as a % of the levels detected in control BSA. Absolute levels of the amino acids quantified accorded with the expected amino acid composition from protein databases. Data are mean + SD for triplicate determinations from separate experiments. * P < 0.05 relative to the corresponding BSA control for each condition, using 2-tailed unpaired t tests. 
